查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1526194

全球人工心臟瓣膜市场

Prosthetic Heart Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 297 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球人工心臟瓣膜市场将达到123亿美元

2023年全球人工心臟瓣膜市场预计为74亿美元，预计到2030年将达到123亿美元，2023-2030年分析期间复合年增长率为7.6%。经导管心臟瓣膜是本报告分析的细分市场之一，预计复合年增长率为 9.8%，到分析期结束时将达到 72 亿美元。在分析期间，组织心臟瓣膜段的成长率估计为 7.1%。

美国市场预计30亿美元，中国预计复合年增长率9.3%

预计2023年美国人工心臟瓣膜市场规模将达30亿美元。中国作为世界第二大经济体，预计2030年市场规模将达12亿美元，2023-2030年分析期间复合年增长率为9.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 7.2% 和 7.1%。在欧洲，德国的复合年增长率预计约为 6.8%。

全球人工心臟瓣膜市场 - 主要趋势和驱动因素总结

人工心臟瓣膜是重要的医疗设备，用于替换受损或患病的心臟瓣膜，以恢復正常的血流并改善患者的预后。这些装置通常分为两种类型：机械瓣膜和生物（组织）瓣膜。机械瓣膜由钛和碳等耐用材料製成，使用寿命长，但需要无限期服用抗凝血剂以防止血栓。由动物组织製成的人工瓣膜，例如牛和猪的心臟瓣膜，耐用性较差，但通常不需要长期抗凝血治疗。这两种类型的人工心臟瓣膜均用于治疗主动脉瓣狭窄、二尖瓣瓣膜闭锁不全和其他可能严重影响心血管系统功能和整体健康的心臟瓣膜疾病。

技术进步极大地改变了人造心臟瓣膜的设计和植入程序。经导管主动脉瓣置换术(TAVR) 等创新正在彻底改变该领域，并为传统心臟直视手术提供微创替代方案。 TAVR 可透过插入小切口（通常在股动脉中）的导管植入人工瓣膜，从而减少恢復时间和併发症，特别是对于高风险患者。此外，3D 超音波心动图和心臟 MRI 等影像技术的改进增强了术前计划和瓣膜尺寸调整，以确保更好的贴合和功能。生物材料的进步也有助于下一代瓣膜的开发，这些瓣膜更能模仿自然组织的特性，并且更耐用且具有生物相容性。为了满足先天性心臟疾病治疗的关键需求，目前正在研究开发可以随儿科患者生长和适应的瓣膜。

人工心臟瓣膜市场的成长是由心臟瓣膜疾病盛行率上升、人口老化和医疗技术进步等多种因素所推动的。心臟瓣膜疾病往往与老龄化相关的退化、风湿性心臟疾病以及高血压和肥胖等文明病有关，增加了瓣膜置换术的需求。世界人口老化进一步加剧了这种需求，因为老年人更容易罹患瓣膜性心臟病。技术的进步，特别是 TAVR 等微创手术技术的进步，正在扩大瓣膜置换术的候选范围，将那些被认为传统手术风险过高的患者纳入其中。此外，新兴地区医疗保健支出的增加和医疗服务的改善正在推动市场扩张。耐用和生物相容性材料的持续开发以及先进影像处理和机器人技术在外科手术中的整合也是主要驱动力。总的来说，这些因素凸显了人工心臟瓣膜市场的动态成长和创新，凸显了其在改善心血管健康和患者生活品质方面的重要作用。

受访企业范例（共28家）

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • St. Jude Medical, Inc.
  • CryoLife, Inc.
  • LivaNova PLC
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt., Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6753

Global Prosthetic Heart Valves Market to Reach US$12.3 Billion by 2030

The global market for Prosthetic Heart Valves estimated at US$7.4 Billion in the year 2023, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Transcatheter Heart Valves, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Tissue Heart Valves segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 9.3% CAGR

The Prosthetic Heart Valves market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Prosthetic Heart Valves Market - Key Trends & Drivers Summarized

Prosthetic heart valves are critical medical devices used to replace damaged or diseased heart valves, restoring normal blood flow and improving patient outcomes. These devices are typically categorized into two main types: mechanical valves and bioprosthetic (tissue) valves. Mechanical valves, made from durable materials like titanium or carbon, are designed to last a lifetime but require patients to take anticoagulant medication indefinitely to prevent blood clots. Bioprosthetic valves, derived from animal tissues such as bovine or porcine heart valves, are less durable but do not usually necessitate long-term anticoagulation therapy. Both types of prosthetic heart valves are used to treat conditions such as aortic stenosis, mitral regurgitation, and other forms of valvular heart disease, which can severely impact cardiovascular function and overall health.

Technological advancements have significantly transformed the design and implantation procedures of prosthetic heart valves. Innovations such as transcatheter aortic valve replacement (TAVR) have revolutionized the field, providing a minimally invasive alternative to traditional open-heart surgery. TAVR allows for the implantation of a prosthetic valve via a catheter inserted through a small incision, typically in the femoral artery, reducing recovery times and complications, especially in high-risk patients. Additionally, improvements in imaging technologies, like 3D echocardiography and cardiac MRI, have enhanced preoperative planning and valve sizing, ensuring better fit and function. Advances in biomaterials have also contributed to the development of next-generation valves that mimic natural tissue properties more closely, offering improved durability and biocompatibility. Research is ongoing to develop valves that can grow and adapt with pediatric patients, addressing a critical need in congenital heart defect management.

The growth in the prosthetic heart valves market is driven by several factors, including the rising prevalence of valvular heart diseases, an aging population, and advancements in medical technology. The increasing incidence of heart valve disorders, often linked to age-related degeneration, rheumatic heart disease, and lifestyle factors such as hypertension and obesity, has led to greater demand for valve replacement procedures. The aging global population further exacerbates this demand, as older adults are more susceptible to heart valve conditions. Technological advancements, particularly in minimally invasive surgical techniques like TAVR, have expanded the candidate pool for valve replacement, including those previously deemed too high-risk for traditional surgery. Additionally, growing healthcare expenditure and improved access to medical services in developing regions are facilitating market expansion. The continuous development of more durable, biocompatible materials and the integration of advanced imaging and robotic technologies into surgical practice are also key drivers. These factors collectively highlight the dynamic growth and innovation within the prosthetic heart valves market, underscoring its critical role in enhancing cardiovascular health and patient quality of life.

Select Competitors (Total 28 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • St. Jude Medical, Inc.
  • CryoLife, Inc.
  • LivaNova PLC
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Heart Valves: Essential for Blood Flow Control
    • Heart Valve Disorders & Diagnosis
    • Replacement or Repair: Treatment Options for Diseased Heart Valves
    • An Introduction to Prosthetic Heart Valves
    • Types of Prosthetic Heart Valves
    • Prosthetic Heart Valves: Global Market Outlook
    • Growing Prevalence of Valvular Heart Disease: An Opportunity for the Market
    • Transcatheter Heart Valves Segment Continues to Boost Market Prospects
    • Developed Regions Lead, Developing Economies to Spearhead Future Growth
    • Competition
    • Global Heart Valves Market Breakdown by Value Sales (in %) for Leading Players: 2023
    • Transcatheter Aortic Valve Replacement Market Breakdown (in %) by Leading Players for 2023
    • World Brands
    • Recent Market Activity
    • Prosthetic Heart Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Demographics and Resultant Rise in Cardiac Disease Drives Market
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Sutureless Valves: Potential Substitutes for Conventional Stentless and Stented Biological Valves
    • Growing Interest in Bioprosthetic Valves across Developed Regions
    • Biological Valves: Continuous Improvements Present Growth Opportunities
    • Artificial Mechanical Heart Valves Come of Age
    • Transcatheter Aortic Valve Replacement (TAVR): Poised for High Growth
    • Expanding Indications & New Valves to Boost TAVR Growth
    • Transcatheter Mitral Valve Regurgitation Treatment Faces Hurdles
    • Pediatric Heart Valve Disease: Choosing Between Repair and Replacement
    • An Insight into Mechanical and Biological Valve Prosthesis
    • Mechanical Vs Biological Heart Valves: A Review
    • Noise Emanated by Mechanical Heart Valves May Lead to Insomnia among Recipients
    • Safety Concerns Shifts Focus towards Stentless Valves
    • Tissue Engineered Aortic Valves: The Future
    • Innovations & Advancements in Heart Valve Market to Propel Growth
    • PoliValve: A New Artificial Heart Valve that is both Durable and Biocompatible
    • Using AI to Customize Prosthetic Heart Valves
    • A Novel Copolymer-based Material to Make Sturdier Artificial Heart Valves
    • Expandable Biomimetic Replacement Heart Valve
    • 3D Printed Heart Valves to Improve TAVR Outcomes
    • MitraClip, Caisson Set to Revolutionize the Valve Space
    • Meril Life Sciences Offers Bioprosthetic Valve
    • Polymer Heart Valves: Potential to Improve Outcomes & Reduced Costs
    • Knitting and Weaving Technologies to Develop Heart Valve Fabric
    • Rise in Healthcare Expenditure Bodes Well for the Market
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Elderly Healthcare Expenditure as a % of GDP for the US, Europe and Japan for 1970, 2010 and 2050
    • Failure of Prosthetic Heart Valve: A Key Concern
    • Symptoms of Malfunctioning Prosthetic Heart Valve
    • Prosthetic Valve Endocarditis (PVE)
    • Prosthetic Valve Thrombosis (PVT)
    • Embolization
    • Structural Breakdown of Bioprosthetic Valves
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 3: World 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 6: World 14-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 9: World 14-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 12: World 14-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 15: World 14-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 18: World 14-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 21: World 14-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 22: World Prosthetic Heart Valves Market Analysis of Annual Sales in US$ Thousand for Years 2016 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Market Overview
    • Deaths due to Valvular Heart Disease: Percentage Breakdown by Valve Disease
    • Number of TAVR Procedures in the US for the Years 2012-2023
    • Aging Population Enhances Risk of Heart Valve Disease, Driving Market Growth
    • US Population by Age Group (in %) for 2018, 2030 & 2050
    • North American Aging Population (in Thousands) by Age Group: 1975-2050
    • Minimally Invasive Surgeries for Aortic Stenosis Treatment Gain Popularity
    • Valve Type and Age: Critical Factors Impacting Success of Heart Valve Replacement Surgery
    • Expanded Indications for Transcatheter Heart Valves
    • TABLE 23: USA Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 25: USA 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 28: USA 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 31: Canada 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 34: Canada 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • JAPAN
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Market Overview
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 37: Japan 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 40: Japan 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • CHINA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Market Overview
    • TABLE 41: China Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 43: China 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 46: China 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • EUROPE
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Market Overview
    • A Peek into the European TAVI Adoption Potential
    • Competition
    • European TAVR Market Breakdown by Leading Competitors (in %) for 2019
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Prosthetic Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 49: Europe 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 52: Europe 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 55: Europe 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • FRANCE
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 58: France 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 61: France 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • GERMANY
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 64: Germany 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 67: Germany 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 70: Italy 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 73: Italy 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • UNITED KINGDOM
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 76: UK 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 79: UK 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 82: Spain 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 85: Spain 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 88: Russia 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 91: Russia 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • ASIA-PACIFIC
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Prosthetic Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • AUSTRALIA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 109: Australia 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 112: Australia 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • INDIA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • Heart Valve Market in India: Attractive Opportunities in Store
    • TABLE 113: India Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 115: India 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 118: India 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 121: South Korea 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 124: South Korea 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • LATIN AMERICA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Prosthetic Heart Valves by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 133: Latin America 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 136: Latin America 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 139: Latin America 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 142: Brazil 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 145: Brazil 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 148: Mexico 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 151: Mexico 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • MIDDLE EAST
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 160: Middle East 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 163: Middle East 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • AFRICA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 164: Africa Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Africa Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 166: Africa 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 167: Africa Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Africa Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 169: Africa 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030

IV. COMPETITION